tiprankstipranks
AbbVie (ABBV)
NYSE:ABBV
US Market

AbbVie Income Statement

Last quarter (Q3 2024), AbbVie's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, AbbVie's net income was $1.56B. See AbbVie’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 33.90B$ 40.64B$ 38.75B$ 30.42B$ 25.83B
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 752.00M$ 778.00M$ 803.00M$ 666.00M$ 464.00M
EBITDA
$ 17.17B$ 24.17B$ 23.93B$ 12.32B$ 12.27B
Operating Income
$ 12.76B$ 18.12B$ 17.92B$ 11.36B$ 12.98B
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ 4.86B$ 11.84B$ 11.54B$ 4.62B$ 7.88B
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

AbbVie Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis